Skanray, a MedTech company specialising in diagnostic imaging, critical care, and surgical solutions, partnered with Tata Elxsi.
The company in a press statement on Monday said that the collaboration is set to transform the field of surgical imaging by integrating advanced core technology and software platforms to enhance diagnostic accuracy and treatment consistency.
Tata Elxsi will spearhead the development of a software platform designed to support all imaging, critical care, and surgical systems within the Skanray ecosystem. This platform will ensure seamless interoperability, compatibility, and multi-modal functionality, incorporating the latest advancements in AI and GenAI technologies.
By combining Skanray’s expertise in medical devices and core technologies with Tata Elxsi’s strengths in medical imaging, software platform development, cloud computing, AI, and analytics, the partnership aims to redefine medical technology. The goal is to create modular, cost-effective, and advanced diagnostic systems.
Pankaj Madhukar Wani, Head of the Healthcare Business Unit at Tata Elxsi, commented, “The diagnostic imaging landscape is being revolutionised by software and digital technologies like cloud and AI. We are thrilled to support Skanray in realising their vision for healthcare. This partnership will foster transformative solutions for healthcare facilities and patients globally.”
Priyanka Chatterjee, VP of Corporate Communications at Skanray Technologies, added, “By merging Skanray’s core technology with Tata Elxsi’s futuristic capabilities, we are set to drive significant advancements in healthcare delivery. Our collaboration will produce solutions that are not only technologically advanced but also user-friendly and cost-effective, ultimately enhancing patient health outcomes.”
